Adaptyv Biosystems
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $48M
Investors
- 5
About Adaptyv Biosystems
Based in Switzerland, Adaptyv Biosystems develops a protein engineering platform using cell-free synthetic biology and nanofluidics. Based in Switzerland and founded in 2021, Adaptyv Biosystems Sàrl operates as a Biopole-based company. Daniel Nakhaee-Zadeh Gutierrez, Amir Shahein, Moustafa Houmani, and Julian Englert are the co-founders of the company. In August 2026, Adaptyv Biosystems Inc. The company develops a protein engineering platform that uses automated nanofluidic platforms and cell-free systems. Rather than depending on genetically modified live cells to manufacture the desired protein, cell-free systems rely solely on biochemical components to convert a DNA sequence into a protein. Cell-free systems can be downsized and automated by avoiding the handling of living cells, making them a fit for high-throughput procedures that screen thousands of protein variations at once.
Who invested in Adaptyv Biosystems
5 investors across 2 rounds
See all investors in Adaptyv Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adaptyv Biosystems
Who invested in Adaptyv Biosystems?
Adaptyv Biosystems has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adaptyv Biosystems raised?
Adaptyv Biosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Adaptyv Biosystems last raise money?
Adaptyv Biosystems's most recent round on record is a Series A, in Aug 2026.
What does Adaptyv Biosystems do?
Based in Switzerland, Adaptyv Biosystems develops a protein engineering platform using cell-free synthetic biology and nanofluidics.
Where is Adaptyv Biosystems headquartered?
Adaptyv Biosystems is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like Adaptyv Biosystems?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Adaptyv Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Adaptyv Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.